The role of FAM46C mutations in the pathogenesis of multiple myeloma and their impact on lenalidomide sensitivity / Linda Patricia Röhner
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
Ulm: 2023 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Röhner, Linda [VerfasserIn] |
|---|---|
| Hochschulschrift: |
| Themen: |
B-Lymphocytes |
|---|
| Umfang: |
VII, 152 Blätter ; Illustrationen, Diagramme (teilweise farbig) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
188287420X |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 188287420X | ||
| 003 | DE-627 | ||
| 005 | 20240311110453.0 | ||
| 007 | tu | ||
| 008 | 240307s2023 gw ||||| m 00| ||eng c | ||
| 035 | |a (DE-627)188287420X | ||
| 035 | |a (DE-599)KXP188287420X | ||
| 035 | |a (OCoLC)1425227176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 100 | 1 | |a Röhner, Linda |e verfasserin |0 (DE-588)1322751862 |0 (DE-627)188287532X |4 aut | |
| 245 | 1 | 4 | |a The role of FAM46C mutations in the pathogenesis of multiple myeloma and their impact on lenalidomide sensitivity |c Linda Patricia Röhner |
| 264 | 1 | |a Ulm |c 2023 | |
| 300 | |a VII, 152 Blätter |b Illustrationen, Diagramme (teilweise farbig) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Universität Ulm |d 2023 | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |c 2024 |f DISS |2 pdager |5 DE-289 | |
| 650 | 2 | |a Multiple myeloma |a Genetics |2 DE-289 | |
| 650 | 2 | |a Multiple myeloma |a Drug therapy |2 DE-289 | |
| 650 | 2 | |a Immunomodulation |2 DE-289 | |
| 650 | 2 | |a B-Lymphocytes |2 DE-289 | |
| 650 | 2 | |a Lenalidomide |2 DE-289 | |
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 689 | 0 | 0 | |D s |0 (DE-588)4127837-9 |0 (DE-627)105721727 |0 (DE-576)209596953 |a Plasmozytom |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4071711-2 |0 (DE-627)106097083 |0 (DE-576)20918471X |a Genetik |2 gnd |
| 689 | 0 | 2 | |D s |0 (DE-588)4076066-2 |0 (DE-627)106083872 |0 (DE-576)209200707 |a Pharmakotherapie |2 gnd |
| 689 | 0 | 3 | |D s |0 (DE-588)1076034888 |0 (DE-627)834101564 |0 (DE-576)444810404 |a Lenalidomid |2 gnd |
| 689 | 0 | |5 (DE-627) | |
| 710 | 2 | |a Universität Ulm |e Grad-verleihende Institution |0 (DE-588)30607-1 |0 (DE-627)100721745 |0 (DE-576)190308001 |4 dgg | |
| 751 | |a Ulm |0 (DE-588)4061529-7 |0 (DE-627)106135341 |0 (DE-576)209140232 |4 uvp | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a ISIL_DE-289 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 951 | |a BO | ||
| 980 | |2 2021 |1 01 |x DE-289 |b 4497112594 |c 00 |f --%%-- |d J-H 15.688 |e --%%-- |j l |y l01 |z 07-03-24 | ||